Requires cost sharing amounts for certain prescription drug benefits to be based on final cost to carrier.
This bill requires health insurance plans in New Jersey to calculate patient cost-sharing (like copays) for prescription drugs based on the final amount the insurer actually pays after negotiations and rebates. Specifically, it mandates that cost-sharing amounts must reflect the carrier's final payment after accounting for any price negotiations with pharmacies and deducting rebates or discounts paid by drug manufacturers. It applies to all health insurance carriers, including state-run programs like the State Health Benefits Program and School Employees' Health Benefits Program. The change aims to ensure patients pay based on the insurer's actual cost, not the original drug price before manufacturer rebates.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2024
Committee Review
Floor Vote
Governor
Introduced Sep 30, 2024
Last action Sep 30, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Sep 30, 2024
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Joe Vitale
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3703
Scope: NJ
Hi! I can help you understand S 3703. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline